functional and cognitive decline. The phenomenology of AD delusions has not been adequately addressed; neither has whether AD delusions relate to specifi c cognitive defi cits. Conclusions: Delusions in AD are common and are related to greater rates of cognitive decline. Future studies that explore the relationship between AD, delusions and cognitive decline need to control for methodological issues and need to examine the phenomenology of delusions and their relationship with specifi c cognitive defi cits.
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Background: Over the past century, consumption of omega-3 polyunsaturated fatty acids has decreased dramatically in Western diets, while consumption of omega-6 has increased. There is mounting evidence suggesting that defi cits in dietary intake of omega-3 are associated with a range of health problems, including mood disorders. This review will outline the epidemiological and clinical evidence for an association between omega-3 depletion and mood disorders, including unipolar, bipolar and perinatal depression and suicide risk. Method: Relevant published studies are reviewed and theories regarding the mechanisms of action are presented. Results: Strong correlations between rates of seafood consumption and mood disorders have been observed in several epidemiological studies. Biochemical studies indicate that omega-3 levels are lower in the tissue of people with depressive disorders than matched controls. The results of several randomized controlled trials indicate that omega-3 supplementation may have therapeutic benefi t for depression suffers, although not all trials have shown a benefi t. Conclusions: Defi cits in omega-3 fatty acids are associated with increased prevalence of mood disorders and offer a potential rational treatment approach. A similar relationship between omega-3 depletion and coronary artery disease may explain the well-described links between coronary artery disease and depression. Inconsistency in clinical trial results to date may refl ect differences in the type and dose of omega-3 supplement chosen, the depression subtype and/or baseline omega-3 levels of the study participants. Spirituality is an important but often overlooked area in mental health. This study aimed to examine individual meanings regarding the concepts of religion and spirituality for adolescents attending a mental health out-patient service. Participants were 53 adolescent out-patients of the Department of Child and Adolescent Mental Health, Prince of Wales Hospital, Sydney, drawn from the early stage of larger study examining adolescent resilience. Adolescents were found to express eclectic and individual views surrounding the topic, with each response being uniquely representative of their beliefs. Themes commonly found included religion and God with many showing some degree of change. Some of these changes involved abandoning one religion in favor of another or changes in ideas about God. There was no signifi cant relationship between those with a diagnosis and those without regarding their religious and spiritual beliefs; however, there were differences between groups in using beliefs to cope, beliefs about a spiritual force and its infl uence on day-to-day and world affairs. Spiritual and religious ideas are important for adolescents and those in the study showed a great diversity in ideas about this topic. It would be of further interest to research how these beliefs and ideas about religion and spiritual change over time and learn about how adolescents without a diagnosis use their beliefs to assist in coping.
Meanings of religion and spirituality for adolescent out-patients

ECT and neuroprotection: a review and proposed study M Pigot, C Loo
School of Psychiatry, University of New South Wales, Sydney, Australia Background: Electroconvulsive therapy (ECT) is a highly effective treatment for depression but its use is limited by associated cognitive side-effects. Several theories have been proposed for the mechanisms underlying cognitive impairment with ECT: excitotoxic damage through infl ux of intracellular calcium or excessive glutamatergic transmission, alteration in opioid receptor density and induction of infl ammatory processes (Krueger et al. 1992; Bazan et al. 2005) . Several neuroprotective agents have been proposed to reduce ECT-related cognitive effects, leading to some trials in animal and human subjects. Method: A comprehensive literature review (PubMed, Medline) identifi ed animal and human clinical research trials of various agents proposed to have a neuroprotective effect on ECT-induced cognitive impairments. Results: Several agents have been shown to reduce memory impairment after electroconvulsive shock (ECS) in rats, for example, calcium channel blockers, opioid receptor antagonists and glucocorticoid antagonists. However, results from clinical trials in humans have been less promising. There are early suggestions that ketamine anesthesia may be associated with fewer cognitive side-effects after ECT (McDaniels et al. 2006) . Conclusions: Strong evidence from ECS models of neuroprotective strategies have to date not been confi rmed in human clinical trials. However, clinical trials have been sparse, with small sample sizes and confounding methodological issues. We propose a randomized sham-controlled study to assess the effect of several neuroprotective agents on ECT-induced cognitive impairment. 
Spatial working memory task
